The clinicopathological and prognostic significance of PSMD14 in cancers based on bioinformatics and meta-analysis
Aim: To evaluate the clinic-pathological features and prognostic value regarding PSMD14 in cancers.Materials & methods: Literature was gathered from public databases until 22 June 2023 to analyze data on survival rates and clinicopathological characteristics associated with PSMD14. TCGA and GEO...
Saved in:
| Main Authors: | Shu-Yi Dong, Shuxin Ding, Zhen Meng, Bo Zou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Future Science OA |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20565623.2024.2409054 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PSMD11 and PSMD14 may serve as novel biomarkers for the prognosis of pancreatic ductal adenocarcinoma
by: Yan-Hui Yang, et al.
Published: (2025-03-01) -
Prognostic biomarker PSMD14 facilitates bladder cancer tumorigenesis and progression by regulating Nucleolin-YAP1 axis
by: Yunfei Wu, et al.
Published: (2025-05-01) -
ALKBH1 knockdown promotes the growth, migration and invasion of HTR-8/SVneo cells through regulating the m5C modification PSMD14
by: Caili Zhang, et al.
Published: (2025-03-01) -
PSMD14 Stabilizes SLC7A11 to Ameliorate Glucocorticoid‐Induced Osteoporosis by Suppressing Osteocyte Ferroptosis
by: Yifeng Shi, et al.
Published: (2025-08-01) -
PSMD14 Transcriptionally Activated by MEF2A Promotes Pancreatic Cancer Development by Upregulating SPON2 Expression
by: Yun‐He Hao, et al.
Published: (2025-05-01)